Streptococcus pneumoniae infection: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
Line 42: Line 42:
==Treatment==
==Treatment==
[[Streptococcus pneumoniae medical therapy|Medical Therapy]] | [[Streptococcus pneumoniae primary prevention|Primary Prevention]] | [[Streptococcus pneumoniae secondary prevention|Secondary Prevention]] | [[Streptococcus pneumoniae cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Streptococcus pneumoniae future or investigational therapies|Future or Investigational Therapies]]
[[Streptococcus pneumoniae medical therapy|Medical Therapy]] | [[Streptococcus pneumoniae primary prevention|Primary Prevention]] | [[Streptococcus pneumoniae secondary prevention|Secondary Prevention]] | [[Streptococcus pneumoniae cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Streptococcus pneumoniae future or investigational therapies|Future or Investigational Therapies]]
==References==
{{reflist|2}}


==Case Studies==
==Case Studies==
Line 51: Line 47:
[[Streptococcus pneumoniae case study one|Case #1]]
[[Streptococcus pneumoniae case study one|Case #1]]


[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
Line 58: Line 52:
[[Category:Streptococcaceae]]
[[Category:Streptococcaceae]]
[[Category:Polysaccharide encapsulated bacteria]]
[[Category:Polysaccharide encapsulated bacteria]]
[[Category:Overview complete]]
{{WH}}
{{WS}}

Revision as of 22:10, 7 August 2015